Proteinase K Market

The global proteinase K market size was estimated to be US$ 72 million in 2022 and is expected to reach US$ 141 million by 2032 at a CAGR of 7%.

Wide use of the protein in the DNA and RNA extraction for in-vitro diagnostics is foreseen to drive market development. Proteinase K has application across in-vitro diagnostics for the expulsion of endotoxins that quandary to ribonuclease A, lysozyme, and other cationic proteins; seclusion of mitochondria from hepatic cells, examination of the confinement of chemicals on films, treatment of paraffin-implanted areas of tissues during counter acting agent naming, and protein absorption from clinical tissue samples. The enzyme is additionally utilized during PCR cleaning for a wide scope of IVD applications.

The capability of proteinase K pretreatment for proficient detection of COVID-19 is foreseen to create ample opportunities for the market growth. Recognition of the COVID-19 infection through the work of RT-qPCR has gained momentum to contain the spread of the COVID-19 pandemic. Also, PCR is viewed as the best quality level innovation for the diagnosis of COVID-19 tainted people. However, high cost and labor-intensiveness associated with RNA extraction of COVID-19 PCR protocol have prompted certain impediments for scaling up of COVID-19 tests across asset restricted settings, wherein research facilities face an absence of prepared staff alongside adequate subsidizing. Accordingly, medical care experts are investigating the capability of altered protocols with direct-to-test augmentations, which can upgrade the accuracy of test outcomes fundamentally separated from helping with extending the capacity of COVID-19 testing.

By geography, North America dominated the global market by holding maximum market share in 2019. The region is expected to maintain its leading position throughout the forecast period. Rising number of patients suffering from cancer has resulted in a rapid increase in polymerase chain reaction (PCR) and next-generation sequencing (NGS) applications. This is estimated to upsurge the demand for proteinase K and other reagents and enzymes needed in PCR and NGS techniques. Moreover, several initiatives taken by public sector and non-profit organizations is anticipated to favor the regional growth. For instance, National Human Genome Research Institute has taken an initiative under NSIGHT (Newborn Sequencing in Genomic Medicine and Public Health) program for screening of new born to detect genetic diseases. This is expected to positively influence the regional growth as the enzyme is significantly being used in molecular biology techniques.

Proteinase K Market Value Share Analysis, by Geography (2022)

The report titled “Proteinase K Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global Proteinase K Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

The global Proteinase K Market is segmented on the basis of type, form, application, end-user, and geography. Based on type, the global market is segmented into Recombinant Proteinase K and Natural Proteinase K. On the basis of form, the global market can be bifurcated into liquid and powder. By application, the global market is divided into Polymerase Chain Reaction (PCR) and Real Time (RT) PCR, Nucleic Acids Isolation, Endotoxin Removal, Mitochondria Isolation, and Others. The end-user segment can be segregated into Contract Research Organization, Bio-Pharmaceutical companies, Academic and Research centers, and Pharmaceutical Companies. Based on geography, the global Proteinase K Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Proteinase K. Further, market share of prominent companies in the global Proteinase K Market would also be estimated.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Proteinase K device companies. The global Proteinase K Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Proteinase K business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Proteinase K Market.

Some of the prominent player involved in global Proteinase K Market include New England Biolabs, A & A Biotechnology, Sigma - Aldrich Co. LLC, Roche Diagnostic GmBH, Promega Corporation, Merck KGaA, QIAGEN, bioWORLD, BLIRT S.A and Thermo Fisher Scientific Inc.

Segmentation:

By Type

• Recombinant Proteinase K
• Natural Proteinase K

By Form

• Powder
• Liquid

By Application

• Polymerase Chain Reaction (PCR) and Real Time (RT) PCR
• Nucleic Acids Isolation
• Endotoxin Removal
• Mitochondria Isolation
• Others

By End-User

• Contract Research Organization 
• Bio-Pharmaceutical companies
• Academic and Research centers
• Pharmaceutical Companies

By Geography

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Belgium
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Rest of Middle East & Africa
• South America
  • Brazil
  • Rest of South America